<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Signal transducer and activator of transcription 3 (STAT3) activation in ischemic brain has been verified </plain></SENT>
<SENT sid="1" pm="."><plain>However, the mechanism and the role of STAT3 activation after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion are poorly elucidated </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study, we sought to test the hypothesis that STAT3 activation after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion was related to reactive oxygen species (ROS) production </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Adult male Sprague-Dawley rats were subjected to focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>STAT3 activation was evaluated by immunohistochemistry and Western blotting </plain></SENT>
<SENT sid="5" pm="."><plain>Rats were subjected to permanent <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> or <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion to clarify the temporal profile of STAT3 activation </plain></SENT>
<SENT sid="6" pm="."><plain>The role of ROS in inducing STAT3 activation was assessed by administration of the ROS scavenger dimethylthiourea (DMTU) </plain></SENT>
<SENT sid="7" pm="."><plain>The effects of DMTU and the STAT3 activation inhibitor AG490 administration on brain ischemic injuries were evaluated by neurologic behavior scores and brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: The activation of STAT3 after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> was significantly increased within peri-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> neurons and astrocytes </plain></SENT>
<SENT sid="9" pm="."><plain>STAT3 activation mainly occurred in the reperfusion phase rather than in the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> phase </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, DMTU suppressed STAT3 activation in a dose-dependent manner, indicating that STAT3 activation may be a subsequent event after ROS production </plain></SENT>
<SENT sid="11" pm="."><plain>DMTU and AG490 significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> sizes and improved neurologic outcomes </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: In comparison with <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, reperfusion is a more powerful stimulus for STAT3 activation </plain></SENT>
<SENT sid="13" pm="."><plain>ROS scavenging is closely correlated with an inhibition of STAT3 activation </plain></SENT>
<SENT sid="14" pm="."><plain>Neuroprotective effects are achieved through ROS scavenging and down-regulation of STAT3 activation </plain></SENT>
</text></document>